654 related articles for article (PubMed ID: 6646897)
41. Genetic deficiency of short-chain acyl-coenzyme A dehydrogenase in cultured fibroblasts from a patient with muscle carnitine deficiency and severe skeletal muscle weakness.
Coates PM; Hale DE; Finocchiaro G; Tanaka K; Winter SC
J Clin Invest; 1988 Jan; 81(1):171-5. PubMed ID: 3335634
[TBL] [Abstract][Full Text] [Related]
42. Immunochemical characterization of variant medium-chain acyl-CoA dehydrogenase in fibroblasts from patients with medium-chain acyl-CoA dehydrogenase deficiency.
Coates PM; Indo Y; Young D; Hale DE; Tanaka K
Pediatr Res; 1992 Jan; 31(1):34-8. PubMed ID: 1594327
[TBL] [Abstract][Full Text] [Related]
43. Mitochondrial β-oxidation of saturated fatty acids in humans.
Adeva-Andany MM; Carneiro-Freire N; Seco-Filgueira M; Fernández-Fernández C; Mouriño-Bayolo D
Mitochondrion; 2019 May; 46():73-90. PubMed ID: 29551309
[TBL] [Abstract][Full Text] [Related]
44. Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation.
Treem WR; Stanley CA; Goodman SI
J Inherit Metab Dis; 1989; 12(2):112-9. PubMed ID: 2502671
[TBL] [Abstract][Full Text] [Related]
45. Dicarboxylic aciduria due to medium chain acyl CoA dehydrogenase defect. A cause of hypoglycemia in childhood.
Divry P; David M; Gregersen N; Kølvraa S; Christensen E; Collet JP; Dellamonica C; Cotte J
Acta Paediatr Scand; 1983 Nov; 72(6):943-9. PubMed ID: 6673498
[TBL] [Abstract][Full Text] [Related]
46. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Jackson S; Bartlett K; Land J; Moxon ER; Pollitt RJ; Leonard JV; Turnbull DM
Pediatr Res; 1991 Apr; 29(4 Pt 1):406-11. PubMed ID: 1830138
[TBL] [Abstract][Full Text] [Related]
47. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver.
Boles RG; Martin SK; Blitzer MG; Rinaldo P
Hum Pathol; 1994 Aug; 25(8):735-41. PubMed ID: 8056418
[TBL] [Abstract][Full Text] [Related]
48. Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
Schuler AM; Wood PA
ILAR J; 2002; 43(2):57-65. PubMed ID: 11917157
[TBL] [Abstract][Full Text] [Related]
49. Intravenous L-carnitine and acetyl-L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency and isovaleric acidemia.
Van Hove JL; Kahler SG; Millington DS; Roe DS; Chace DH; Heales SJ; Roe CR
Pediatr Res; 1994 Jan; 35(1):96-101. PubMed ID: 8134205
[TBL] [Abstract][Full Text] [Related]
50. Slc22a5 haploinsufficiency does not aggravate the phenotype of the long-chain acyl-CoA dehydrogenase KO mouse.
Ranea-Robles P; Yu C; van Vlies N; Vaz FM; Houten SM
J Inherit Metab Dis; 2020 May; 43(3):486-495. PubMed ID: 31845336
[TBL] [Abstract][Full Text] [Related]
51. Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province.
Yang C; Shi C; Zhou C; Wan Q; Zhou Y; Chen X; Jin X; Huang C; Xu P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):472-480. PubMed ID: 34704412
[TBL] [Abstract][Full Text] [Related]
52. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency.
Yamaguchi S; Indo Y; Coates PM; Hashimoto T; Tanaka K
Pediatr Res; 1993 Jul; 34(1):111-3. PubMed ID: 8356011
[TBL] [Abstract][Full Text] [Related]
53. Immunochemical characterization of variant long-chain acyl-CoA dehydrogenase in cultured fibroblasts from nine patients with long-chain acyl-CoA dehydrogenase deficiency.
Indo Y; Coates PM; Hale DE; Tanaka K
Pediatr Res; 1991 Sep; 30(3):211-5. PubMed ID: 1945557
[TBL] [Abstract][Full Text] [Related]
54. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
[TBL] [Abstract][Full Text] [Related]
55. Plasma free fatty acids in mitochondrial fatty acid oxidation defects.
Martínez G; Jiménez-Sánchez G; Divry P; Vianey-Saban C; Riudor E; Rodés M; Briones P; Ribes A
Clin Chim Acta; 1997 Nov; 267(2):143-54. PubMed ID: 9469249
[TBL] [Abstract][Full Text] [Related]
56. Defects of fatty-acid oxidation in muscle.
Angelini C
Baillieres Clin Endocrinol Metab; 1990 Sep; 4(3):561-82. PubMed ID: 2268228
[TBL] [Abstract][Full Text] [Related]
57. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
Cox KB; Hamm DA; Millington DS; Matern D; Vockley J; Rinaldo P; Pinkert CA; Rhead WJ; Lindsey JR; Wood PA
Hum Mol Genet; 2001 Sep; 10(19):2069-77. PubMed ID: 11590124
[TBL] [Abstract][Full Text] [Related]
58. Impaired amino acid metabolism contributes to fasting-induced hypoglycemia in fatty acid oxidation defects.
Houten SM; Herrema H; Te Brinke H; Denis S; Ruiter JP; van Dijk TH; Argmann CA; Ottenhoff R; Müller M; Groen AK; Kuipers F; Reijngoud DJ; Wanders RJ
Hum Mol Genet; 2013 Dec; 22(25):5249-61. PubMed ID: 23933733
[TBL] [Abstract][Full Text] [Related]
59. Milder childhood form of very long-chain acyl-CoA dehydrogenase deficiency in a 6-year-old Japanese boy.
Doi T; Abo W; Tateno M; Hayashi K; Hori T; Nakada T; Fukao T; Takahashi Y; Terada N
Eur J Pediatr; 2000 Dec; 159(12):908-11. PubMed ID: 11131350
[TBL] [Abstract][Full Text] [Related]
60. The measurement of carnitine and acyl-carnitines: application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxidation.
Bhuiyan AK; Jackson S; Turnbull DM; Aynsley-Green A; Leonard JV; Bartlett K
Clin Chim Acta; 1992 May; 207(3):185-204. PubMed ID: 1327583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
